Advisor Group Holdings, Inc. Dyne Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 27 shares of DYN stock, worth $384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 8,525
99.68%
Holding current value
$384
Previous $200,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$147 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$138 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$130 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$105 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $737M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...